98%
921
2 minutes
20
Background: Histogram parameters from synthetic magnetic resonance imaging (SyMRI) may provide more diagnostic information than mean values in differentiating benign from malignant sinonasal tumors. The histopathologic basis of SyMRI in characterizing malignant sinonasal tumors is still unclear. This study aimed to explore the potential value of SyMRI quantitative maps with whole-lesion histogram analysis in the diagnosis of benign and malignant sinonasal tumors and the correlations between SyMRI-derived histogram metrics and histopathologic features in malignant sinonasal tumors.
Methods: A total of 76 patients (29 benign and 47 malignant) with sinonasal tumors were enrolled. Nine histogram parameters of the whole tumor were extracted from T1, T2, and proton density (PD) quantitative maps, respectively. Univariate and multivariate analyses were utilized to explore the association between benign and malignant sinonasal tumors. Models based on single, combined quantitative maps, and clinical features were established to evaluate the diagnostic performance. The Spearman correlation coefficient was used to assess the correlation between histogram quantitative metrics of SyMRI and histopathological features.
Results: For SyMRI parameters, 18 histogram metrics showed significant differences between benign and malignant sinonasal tumors (all P<0.05). The combined model based on T2 map (T2-90th percentile, Minimum, and Kurtosis) and clinical features (age and bone destruction) attained the best diagnostic performance in discrimination of benign and malignant sinonasal tumors with the highest area under the curve (AUC) of 0.908, sensitivity of 91.5%, and specificity of 82.8%. Moreover, several histogram quantitative parameters of malignancies were correlated with Ki-67 (r=-0.465 to -0.28), p53 (r=-0.476 to 0.414) and epidermal growth factor receptor (EGFR) status (r=-0.428/0.419). The T2-90th Percentile was independently associated with Ki-67 labeling index (LI) (P<0.05).
Conclusions: Whole-tumor histogram quantitative parameters of SyMRI could further improve the diagnostic performance in differentiating benign from malignant sinonasal tumors and may serve as potential biomarkers in assessing the histopathologic features.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12332716 | PMC |
http://dx.doi.org/10.21037/qims-2024-2564 | DOI Listing |
Cureus
August 2025
Department of Oncology, University of Warmia and Mazury in Olsztyn, Olsztyn, POL.
Management of recurrent adenoid cystic carcinoma (ACC) in elderly patients remains challenging due to comorbidities, functional impairments, and anatomically complex tumor locations that complicate surgical access and increase operative risk. The ZAP-X Gyroscopic Radiosurgery System (ZAP Surgical Systems, Inc., San Carlos, CA, USA) offers a highly precise, non-invasive treatment modality, potentially suitable for salvage therapy in previously irradiated fields and in medically inoperable patients.
View Article and Find Full Text PDFHead Neck
September 2025
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Background: Flap complications following maxillectomy, reconstruction, and adjuvant proton beam therapy (PBT) for primary maxillary and sinonasal malignancies are not well described.
Methods: This retrospective cohort study included consecutive patients treated between 2016 and 2023 from a single-institutional database.
Results: Thirteen patients were identified with a median follow-up of 26 months.
Am J Case Rep
September 2025
Department of Otolaryngology - Head and Neck Surgery, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
BACKGROUND Pediatric sinonasal tumors are rare, accounting for about 4% of all pediatric head and neck neoplasms. Due to their nonspecific symptoms such as nasal obstruction, epistaxis, and facial pain, these tumors often present diagnostic challenges and lead to delays in managment. Early and accurate diagnosis is crucial to optimize clinical outcomes.
View Article and Find Full Text PDFLab Invest
September 2025
Department of Pathology and Laboratory Medicine, University of California, Irvine, CA, USA. Electronic address:
Sinonasal mucosal melanoma (SNMM) is a rare aggressive malignancy of the sinonasal tract. Due to its advanced clinical presentation and frequent late-stage diagnosis, the 5-year survival rate is less than 30%, with an even worse prognosis in patients with distant metastasis (SNMM-M). Therefore, characterizing the molecular landscape of SNMM may provide novel therapeutic targets for SNMM-M.
View Article and Find Full Text PDFInt Forum Allergy Rhinol
September 2025
Department of Otolaryngology, University of California Irvine, Irvine, California, USA.
The goal of this American Rhinologic Society expert practice statement (EPS) is to summarize the best available evidence for surveillance strategies following definitive treatment of sinonasal malignancy. Topics discussed include components of surveillance, including endoscopy and imaging subtypes, frequency and length of surveillance, and highlights of some specific pathologies that warrant special consideration. This EPS was developed following the recommended methodology and approval process as previously outlined.
View Article and Find Full Text PDF